Clinical Trial of SB-509 in Subjects With Amyotrophic Lateral Sclerosis (ALS)

Clinical trial NCT00748501 · COMPLETED

Trial details

NCT number: NCT00748501
Sponsor: Sangamo Therapeutics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis

Start date: 2008-09-01
Primary completion: 2010-06-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.